BACKGROUND: Telemonitoring interventions featuring transmission of home glucose records to healthcare providers have resulted in improved glycemic control in patients with diabetes. No research has addressed the intensity or duration of telemonitoring required to sustain such improvements. PURPOSE: The DiaTel study (10 January 2005 to 1 November 2007) compared active care management (ACM) with home telemonitoring (n=73) to monthly care coordination (CC) telephone calls (n=77) among veterans with diabetes and suboptimal glycemic control. The purpose of the DiaTel Extension was to assess whether initial improvements could be sustained with interventions of the same or lower intensity among participants who re-enrolled in a 6-month extension of DiaTel. METHODS:DiaTel participants receiving ACM were re-assigned randomly to monthly CC calls with continued telemonitoring but no active medication management (ACM-to-CCHT, n=23) or monthly CC telephone calls (ACM-to-CC, n=21). DiaTel participants receiving CC were re-assigned randomly to continued CC (CC-to-CC, n=28) or usual care (UC, ie, CC-to-UC, n=29). Hemaglobin A1c (HbA1c) was assessed at 3 and 6 months following re-randomization. RESULTS: Marked HbA1c improvements observed in DiaTel ACM participants were sustained 6 months after re-randomization in both ACM-to-CCHT and ACM-to-CC groups. Lesser HbA1c improvements observed in DiaTel CC participants were sustained in both CC-to-CC and CC-to-UC groups. No benefit was apparent for continued transmission of glucose data among DiaTel ACM participants or continued monthly telephone calls among DiaTel CC participants 6 months after re-randomization. CONCLUSION: Significant improvements in HbA1c achieved using home telemonitoring and active medication management for 6 months were sustained 6 months later with interventions of decreased intensity in VA Health System-qualified veterans. CLINICAL TRIAL REG. NO: NCT00245882, http://www.clinicaltrials.gov.
RCT Entities:
BACKGROUND: Telemonitoring interventions featuring transmission of home glucose records to healthcare providers have resulted in improved glycemic control in patients with diabetes. No research has addressed the intensity or duration of telemonitoring required to sustain such improvements. PURPOSE: The DiaTel study (10 January 2005 to 1 November 2007) compared active care management (ACM) with home telemonitoring (n=73) to monthly care coordination (CC) telephone calls (n=77) among veterans with diabetes and suboptimal glycemic control. The purpose of the DiaTel Extension was to assess whether initial improvements could be sustained with interventions of the same or lower intensity among participants who re-enrolled in a 6-month extension of DiaTel. METHODS: DiaTel participants receiving ACM were re-assigned randomly to monthly CC calls with continued telemonitoring but no active medication management (ACM-to-CCHT, n=23) or monthly CC telephone calls (ACM-to-CC, n=21). DiaTel participants receiving CC were re-assigned randomly to continued CC (CC-to-CC, n=28) or usual care (UC, ie, CC-to-UC, n=29). Hemaglobin A1c (HbA1c) was assessed at 3 and 6 months following re-randomization. RESULTS: Marked HbA1c improvements observed in DiaTel ACM participants were sustained 6 months after re-randomization in both ACM-to-CCHT and ACM-to-CC groups. Lesser HbA1c improvements observed in DiaTel CC participants were sustained in both CC-to-CC and CC-to-UC groups. No benefit was apparent for continued transmission of glucose data among DiaTel ACM participants or continued monthly telephone calls among DiaTel CC participants 6 months after re-randomization. CONCLUSION: Significant improvements in HbA1c achieved using home telemonitoring and active medication management for 6 months were sustained 6 months later with interventions of decreased intensity in VA Health System-qualified veterans. CLINICAL TRIAL REG. NO: NCT00245882, http://www.clinicaltrials.gov.
Authors: H Peter Chase; Jerusha A Pearson; Clare Wightman; Mary D Roberts; Adam D Oderberg; Satish K Garg Journal: Diabetes Care Date: 2003-05 Impact factor: 19.112
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: R Bellazzi; C Larizza; S Montani; A Riva; M Stefanelli; G d'Annunzio; R Lorini; E J Gomez; E Hernando; E Brugues; J Cermeno; R Corcoy; A de Leiva; C Cobelli; G Nucci; S Del Prato; A Maran; E Kilkki; J Tuominen Journal: Comput Methods Programs Biomed Date: 2002-08 Impact factor: 5.428
Authors: Victor M Montori; Pamela K Helgemoe; Gordon H Guyatt; Diana S Dean; Teresa W Leung; Steven A Smith; Yogish C Kudva Journal: Diabetes Care Date: 2004-05 Impact factor: 19.112
Authors: Steven Shea; Ruth S Weinstock; Jeanne A Teresi; Walter Palmas; Justin Starren; James J Cimino; Albert M Lai; Lesley Field; Philip C Morin; Robin Goland; Roberto E Izquierdo; Susana Ebner; Stephanie Silver; Eva Petkova; Jian Kong; Joseph P Eimicke Journal: J Am Med Inform Assoc Date: 2009-04-23 Impact factor: 4.497
Authors: Kelly P McCarrier; James D Ralston; Irl B Hirsch; Ginny Lewis; Diane P Martin; Frederick J Zimmerman; Harold I Goldberg Journal: Diabetes Technol Ther Date: 2009-04 Impact factor: 6.118
Authors: Roslyn A Stone; R Harsha Rao; Mary Ann Sevick; Chunrong Cheng; Linda J Hough; David S Macpherson; Carol M Franko; Rebecca A Anglin; D Scott Obrosky; Frederick R Derubertis Journal: Diabetes Care Date: 2009-12-15 Impact factor: 19.112
Authors: Cheryl P Lynch; Mulugeta Gebregziabher; R Neal Axon; Kelly E Hunt; Elizabeth Payne; Leonard E Egede Journal: J Gen Intern Med Date: 2014-08-16 Impact factor: 5.128
Authors: Lynn Nuti; Ayten Turkcan; Mark A Lawley; Lingsong Zhang; Laura Sands; Sara McComb Journal: BMC Health Serv Res Date: 2015-09-02 Impact factor: 2.655
Authors: Tuula Karhula; Anna-Leena Vuorinen; Katja Rääpysjärvi; Mira Pakanen; Pentti Itkonen; Merja Tepponen; Ulla-Maija Junno; Tapio Jokinen; Mark van Gils; Jaakko Lähteenmäki; Kari Kohtamäki; Niilo Saranummi Journal: J Med Internet Res Date: 2015-06-17 Impact factor: 5.428
Authors: Deborah A Greenwood; Shelley A Blozis; Heather M Young; Thomas S Nesbitt; Charlene C Quinn Journal: J Med Internet Res Date: 2015-07-21 Impact factor: 5.428
Authors: Michelle M Alvarado; Hye-Chung Kum; Karla Gonzalez Coronado; Margaret J Foster; Pearl Ortega; Mark A Lawley Journal: J Med Internet Res Date: 2017-02-13 Impact factor: 5.428